Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients

This study aimed to investigate the associations of microRNA (miRs) signatures with cytokines, serum lipids, and disease activity in patients with psoriatic arthritis (PsA), ankylosing spondylitis (AS), and rheumatoid arthritis (RA). In total, 65 patients (PsA <i>n</i> = 25, AS <i>...

Full description

Bibliographic Details
Main Authors:	Krzysztof Bonek, Ewa Kuca Warnawin, Anna Kornatka, Magdalena Plebańczyk, Tomasz Burakowski, Włodzimierz Maśliński, Małgorzata Wisłowska, Piotr Głuszko, Marzena Ciechomska
Format:	Article
Language:	English
Published:	MDPI AG 2022-04-01
Series:	Biomedicines
Subjects:	miRNA psoriatic arthritis rheumatoid arthritis ankylosing spondylitis inflammation lipids
Online Access:	https://www.mdpi.com/2227-9059/10/4/893

Similar Items

Ankylosing spondylitis and psoriatic arthritis: clinical and economic consequences of the use of etanercept
by: Viola Sacchi, et al.
Published: (2010-06-01)

Associations of IL-18 with Altered Cardiovascular Risk Profile in Psoriatic Arthritis and Ankylosing Spondylitis
by: Krzysztof Bonek, et al.
Published: (2022-01-01)

Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
by: M. Rossini, et al.
Published: (2015-03-01)

Secukinumab for ankylosing spondylitis and psoriatic arthritis
by: Lubrano E, et al.
Published: (2016-10-01)

Short-term Efficacy and Safety of Secukinumab in Pakistani Patients with Ankylosing Spondylitis and Psoriatic Arthritis
by: Sumera Ghani, et al.
Published: (2023-06-01)

Real-Life Retention Rates and Reasons for Switching of Biological DMARDs in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
by: Vandana Bhushan, et al.
Published: (2021-09-01)

Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
by: M. Elaine Husni, et al.
Published: (2022-03-01)

Association between use of disease-modifying antirheumatic drugs and diabetes in patients with ankylosing spondylitis, rheumatoid arthritis, or psoriasis/psoriatic arthritis: a nationwide, population-based cohort study of 84,989 patients
by: Chen HH, et al.
Published: (2017-05-01)

Maternal Interleukin-17 and disease activity influence pregnancy outcomes in women with psoriatic arthritis and ankylosing spondylitis
by: Ehab F. Girbash, et al.
Published: (2023-01-01)

SIGNIFICANCE OF PERIPHERAL ARTHRITIS IN ANKYLOSING SPONDYLITIS
by: Sh. F. Erdes, et al.
Published: (2014-06-01)

Inflammatory back pain in psoriatic arthritis is significantly more responsive to corticosteroids compared to back pain in ankylosing spondylitis: a prospective, open-labelled, controlled pilot study
by: Muhammad Haroon, et al.
Published: (2018-04-01)

Coexistence of rheumatoid arthritis and ankylosing spondylitis
by: Tacjana Anna Barczyńska, et al.
Published: (2015-12-01)

Use of antidepressants and benzodiazepine-related hypnotics before and after initiation of TNF-α inhibitors or non-biological systemic treatment in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis
by: Philip Brenner, et al.
Published: (2020-02-01)

Longitudinal profiling of the gut microbiome in patients with psoriatic arthritis and ankylosing spondylitis: a multicentre, prospective, observational study
by: Jesus Miguens Blanco, et al.
Published: (2020-11-01)

Characteristics of patients with psoriatic arthritis in Korea: focusing on axial involvement
by: Hanna Park, et al.
Published: (2024-01-01)

Budget impact model of secukinumab for the treatment of moderate-to-severe psoriasis, psoriatic arthritis, and ankylosing spondylitis in Italy: a cross-indication initiative
by: Colombo GL, et al.
Published: (2018-08-01)

The Effects of Biologics on Hematologic Malignancy Development in Patients with Ankylosing Spondylitis, Psoriasis, or Psoriatic Arthritis: A National Cohort Study
by: Chia-Jung Tsai, et al.
Published: (2023-09-01)

IL-33 Gene Polymorphisms as Potential Biomarkers of Disease Susceptibility and Response to TNF Inhibitors in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Patients
by: Milena Iwaszko, et al.
Published: (2021-06-01)

Association between syndesmophyte and metabolic syndrome in patients with psoriatic arthritis or ankylosing spondylitis: a cross-sectional study
by: Chonachan Petcharat, et al.
Published: (2021-04-01)

Long-term Safety of Secukinumab Over Five Years in Patients with Moderate-to-severe Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Update on Integrated Pooled Clinical Trial and Post-marketing Surveillance Data
by: Alice B. Gottlieb, et al.
Published: (2022-04-01)

Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study
by: Karin Bengtsson, et al.
Published: (2017-05-01)

Treatment Pattern Analysis and Health-care Resource Consumption on Patients with Psoriatic Arthritis or Ankylosing Spondylitis Treated with Biological Drugs in a Northern Italian Region
by: Perrone V, et al.
Published: (2020-06-01)

Serum bone-turnover biomarkers are associated with the occurrence of peripheral and axial arthritis in psoriatic disease: a prospective cross-sectional comparative study
by: Deepak R. Jadon, et al.
Published: (2017-09-01)

The spiritual well-being of patients with ankylosing spondylitis and rheumatoid arthritis
by: Raikan Buyukavci, et al.
Published: (2022-03-01)

Why Inhibition of IL-23 Lacked Efficacy in Ankylosing Spondylitis
by: Dennis McGonagle, et al.
Published: (2021-03-01)

TEMPOROMANDIBULAR JOINT INVOLVEMENT IN RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS: A CROSS-SECTIONAL STUDY
by: Cristina Iordache, et al.
Published: (2018-01-01)

Gait characteristics associated with the foot and ankle in inflammatory arthritis: a systematic review and meta‐analysis
by: Matthew Carroll, et al.
Published: (2015-01-01)

Osteoarticular Involvement-Associated Biomarkers and Pathways in Psoriasis: The Shared Pathway With Ankylosing Spondylitis
by: Yu-Ping Zhang, et al.
Published: (2022-03-01)

Rheumatoid arthritis and spondyloarthritis prevalence in four European countries - a comparative study
by: Zlatković-Švenda Mirjana, et al.
Published: (2022-01-01)

Persistence to subcutaneous biological agents in Hungarian patients treated for inflammatory arthritis
by: Takacs P, et al.
Published: (2019-01-01)

Newly diagnosed seropositive rheumatoid arthritis in a 52-year-old man superimposed on long-standing ankylosing spondylitis during secukinumab treatment
by: Jaroslaw Nowakowski, et al.
Published: (2023-10-01)

Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study
by: Joshua L. Lee, et al.
Published: (2018-08-01)

Significance of Interleukin (IL)-4 and IL-13 in Inflammatory Arthritis
by: Milena Iwaszko, et al.
Published: (2021-11-01)

Nod-like receptors in inflammatory arthritis
by: Sahib Singh Madahar, et al.
Published: (2024-02-01)

Reactive Arthritis Triggered by Adalimumab and Leflunomide in a Patient with Ankylosing Spondylitis
by: Liu Y, et al.
Published: (2022-12-01)

Machine learning-based prediction model for responses of bDMARDs in patients with rheumatoid arthritis and ankylosing spondylitis
by: Seulkee Lee, et al.
Published: (2021-10-01)

Rheumatoid arthritis and ankylosing spondylitis with cervical involvement and characteristics
by: Nevsun Pihtili Tas, et al.
Published: (2019-06-01)

Disease Differentiation and Monitoring of Anti-TNF Treatment in Rheumatoid Arthritis and Spondyloarthropathies
by: Katarzyna Bogunia-Kubik, et al.
Published: (2021-07-01)

Inflammatory arthritis and eye diseases: a Mendelian randomization study
by: Xinlin Nie, et al.
Published: (2023-10-01)

IS PSORIATIC ARTHRITIS REALLY PSORIATIC?
by: Sh. F. Erdes
Published: (2014-12-01)